WORLD(Australia/Medtech/Urology) - NinaMED launches with $13.75M in financing led by SPRIM Global Investments to develop and commercialize the NiNA System, a non‑invasive, at‑home, drug‑free neuromodulation device for overactive bladder (OAB), under